Compare ONCY & AUBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONCY | AUBN |
|---|---|---|
| Founded | 1998 | 1907 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.7M | 88.8M |
| IPO Year | 2002 | 1996 |
| Metric | ONCY | AUBN |
|---|---|---|
| Price | $0.94 | $27.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.33 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 1.5K |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.61% |
| EPS Growth | N/A | ★ 13.66 |
| EPS | N/A | ★ 0.63 |
| Revenue | N/A | ★ $619,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,505.00 | N/A |
| P/E Ratio | ★ N/A | $43.25 |
| Revenue Growth | N/A | ★ 0.81 |
| 52 Week Low | $0.71 | $21.60 |
| 52 Week High | $1.51 | $29.00 |
| Indicator | ONCY | AUBN |
|---|---|---|
| Relative Strength Index (RSI) | 52.82 | 62.98 |
| Support Level | $0.90 | $24.18 |
| Resistance Level | $1.06 | $28.14 |
| Average True Range (ATR) | 0.06 | 0.58 |
| MACD | 0.01 | 0.24 |
| Stochastic Oscillator | 62.80 | 64.69 |
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
Auburn National Bancorp Inc is a bank holding company registered with the Board of Governors of the Federal Reserve System (the Federal Reserve). As a bank holding company, the Company may diversify into a broader range of financial services and other business activities than are currently permitted to the Bank under applicable laws and regulations. The holding company structure also provides greater financial and operating flexibility than is presently permitted to the Bank. The Company's business is conducted through the Bank and its subsidiaries. Although it has no immediate plansto conduct any other business, the Company may engage directly or indirectly in several activities closely related to banking permitted by the Federal Reserve.